Even vulnerable people, who are at risk of severe Covid-19, achieved good antibody levels after three doses of mRNA vaccine. This is shown by a study from the University of Gothenburg on patients having undergone a bone...
Nine out of 10 U.S. academic scientists surveyed believe scientists have a part to play in reducing vaccine hesitancy among the public, a research team from Arizona State University’s Center for Science, Technology and...
Part 1 of the series on COVID-19 presented by Prof. Schmitt, Prof. Weil-Olivier, and Dr. Karafillakis. 00:00 Introduction 01:46 Attitude changes to COVID-19 during the pandemic 09:46 Is there an inverse relationship...
Scientists at Washington University in St. Louis have developed a breath test that quickly identifies those who are infected with the virus that causes COVID-19. The device requires only one or two breaths and provides...
Artificial intelligence is a new addition to the infectious disease researcher’s toolbox. Yet in merely half a decade, AI has accelerated progress on some of the most urgent issues in medical science and public health...
Forty-fourth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 00:35 Dengue epidemiology 01:00 Transmission between mosquitoes and humans 01:58 Dengue risk by area 02:41...
International scientists have evaluated molecular mechanisms responsible for heterogeneous responses to influenza vaccination among older adults. They have identified potential immunological mediators that suppress the...
Forty-third Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 00:35 Dengue phases 01:30 Clinical signs of dengue fever 02:25 Antibody disease enhancement 03:05 Diseases...